155 related articles for article (PubMed ID: 22232910)
1. [Cerebrovascular and antiserotoninergic activity of the combination of tropoxin and mexidol].
Gorbunov AA; Gan'shina TS; Turilova AI; Mirzoian RS
Eksp Klin Farmakol; 2011; 74(8):23-7. PubMed ID: 22232910
[TBL] [Abstract][Full Text] [Related]
2. [Influence of 2-ethyl-6-methyl-3-hydroxypyridine hemisuccinate on cerebral blood perfusion in rats under experimental pathology conditions].
Gan'shina TS; Gorbunov AA; Gnezdilova AV; Kurdiumov IN; Avdiunina NI; Piatin BM; Mirzoian RS
Eksp Klin Farmakol; 2011; 74(8):17-22. PubMed ID: 22232909
[TBL] [Abstract][Full Text] [Related]
3. [Effect of tropoxin on cerebrovascular effects of meta-chlorophenylpiperazine and serotonin].
Gorbunov AA; Gan'shina TS; Mirzoian RS
Eksp Klin Farmakol; 2010 Sep; 73(9):13-6. PubMed ID: 21086646
[TBL] [Abstract][Full Text] [Related]
4. [Tropoxin and cerebrovascular effects of serotonin].
Mirzoian RS; Topchian AV; Gan'shina TS; Kostochka LM
Eksp Klin Farmakol; 2000; 63(3):21-3. PubMed ID: 10934590
[TBL] [Abstract][Full Text] [Related]
5. [The effect of tropoxin on the neurogenic and vasogenic inflammation of the dura mater vessels].
Amelin AV; Ivanov VE; Ignatov IuD; Tumelevich BCh; Pushkarev AA; Usachev NI
Eksp Klin Farmakol; 1999; 62(4):14-7. PubMed ID: 10513329
[TBL] [Abstract][Full Text] [Related]
6. [The anti-ischemic effects of 3-hydroxypyridine derivatives in cerebrovascular pathology].
Pogorelyĭ VE; Arl't AV; Gaevyĭ MD; Gatsura VV; Smirnov LD
Eksp Klin Farmakol; 1999; 62(5):15-7. PubMed ID: 10572744
[TBL] [Abstract][Full Text] [Related]
7. [Tropoxin--a new serotonin antagonist and potential antimigraine agent].
Mirzoian RS; Seredenin SB; Gan'shina TS; Kostochka LM; Romanycheva NA; Rusakov DIu
Eksp Klin Farmakol; 1998; 61(3):28-31. PubMed ID: 9690072
[TBL] [Abstract][Full Text] [Related]
8. [Effect of mexidol on combined vascular pathology of brain and heart].
Gnezdilova AV; Lebedeva MA; Gan'shina TS; Mirzoian RS
Eksp Klin Farmakol; 2011; 74(6):20-3. PubMed ID: 21870770
[TBL] [Abstract][Full Text] [Related]
9. [Effect of the new antimigraine drug serotonin receptor antagonist tropoxin on platelet aggregation].
Vasil'eva TM; Petrukhina GN; Miftakhova NT; Makarov VA; Gan'shina TS; Bezhanian SG; Mirzoian RS
Eksp Klin Farmakol; 2005; 68(3):30-3. PubMed ID: 16047677
[TBL] [Abstract][Full Text] [Related]
10. [Neurotransmitter mechanism of the tropoxin effect in comparison with other antimigraine preparations].
Gan'shina TS
Eksp Klin Farmakol; 2003; 66(3):17-20. PubMed ID: 12924226
[TBL] [Abstract][Full Text] [Related]
11. [Metabolic effects of mexidol in complex treatment of chronic brain ischemia].
Demchenko EIu; Kulakova NV; Semiglazova TA; Golovacheva AB; Borodulina EV; Udut VV
Eksp Klin Farmakol; 2008; 71(6):13-5. PubMed ID: 19140508
[TBL] [Abstract][Full Text] [Related]
12. [Cerebrovascular effects of GABA conjugate with arachidonic acid under conditions of separate and combined vascular pathology of brain and heart].
Gnezdilova AV; Gan'shina TS; Maslennikov DV; Bezuglov VV; Gretskaia NM; Mirzoian RS
Eksp Klin Farmakol; 2011; 74(8):28-31. PubMed ID: 22232911
[TBL] [Abstract][Full Text] [Related]
13. [Interaction of tropoxin and its molecular fragments tropan and 3,4,5-trimethoxybenzoate with serotonin receptors of cortical neurons in the rat brain (a microionophoretic study)].
Kozhechkin SN; Kostochka LM; Bezhanian SG; Mirzoian RS; Seredin SB
Eksp Klin Farmakol; 2005; 68(4):3-6. PubMed ID: 16193647
[TBL] [Abstract][Full Text] [Related]
14. [Cerebrovascular serotonin antagonists and agonist among tropan derivatives].
Gan'shina TS; Bezhanian SG; Kostochka LM; Volkova MIu; Mirsoian RS
Eksp Klin Farmakol; 2008; 71(1):26-30. PubMed ID: 18365483
[TBL] [Abstract][Full Text] [Related]
15. [The assessment of the clinical efficacy, vasoactive and metabolic effects of mexidol in elderly patients with discirculatory encephalopathy].
Abramenko IuV
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(11 Pt 1):35-41. PubMed ID: 22611676
[TBL] [Abstract][Full Text] [Related]
16. [The effect of 3-hydroxypyridine derivatives on postischemic disorders in the autoregulatory reactions of the cerebral vessels].
Pogorelyĭ VE; Arl't AV; Gaevyĭ MD; Smirnov LD; Gatsura VV
Eksp Klin Farmakol; 1997; 60(4):22-4. PubMed ID: 9376750
[TBL] [Abstract][Full Text] [Related]
17. [The action of emoxipin, lithium oxybutyrate and pikamilon on the blood circulation of the ischemic brain].
Pogorelyĭ VE; Gaevyĭ MD
Eksp Klin Farmakol; 1999; 62(6):26-8. PubMed ID: 10650522
[TBL] [Abstract][Full Text] [Related]
18. [GABAergic mechanism of cerebrovasculareffect of mexidol].
gnezdilova AV; Gan'shina TS; Mirzoian RS
Eksp Klin Farmakol; 2010 Oct; 73(10):11-3. PubMed ID: 21254506
[TBL] [Abstract][Full Text] [Related]
19. [The study of the efficacy and safety of Mexidol and Mexidol Forte 250 in patients with chronic cerebral ischemia].
Kutashov VA; Ulyanova OV
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(12. Vyp. 2):89-92. PubMed ID: 32207723
[TBL] [Abstract][Full Text] [Related]
20. [Effect of semax and mexidol on brain ischemia models in rats].
Iasnetsov VV; Voronina TA
Eksp Klin Farmakol; 2009; 72(1):68-70. PubMed ID: 19334516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
